Baudax Bio, Inc. (BXRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST
Baudax Bio Revenue
Baudax Bio had revenue of $1.27M in the twelve months ending September 30, 2023, up 217.25% year-over-year. In the year 2022, Baudax Bio had annual revenue of $1.27M with 17.50% growth.
Revenue
1.27M
Revenue Growth
+217.25%
P/S Ratio
0.00
Revenue / Employee
141.00K
Employees
9
Market Cap
52.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 1.27M | 189.00K | 17.50% |
| Dec 31, 2021 | 1.08M | 587.00K | 119.07% |
| Dec 31, 2020 | 493.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genocea Biosciences | 1.91M |
| Mymetics | 564.14K |
| Cardax | 500.71K |
| Core One Labs | 338.91K |
| Bioasis Technologies | 199.01K |
| Panacos Pharmaceuticals | 99.00K |
| Athersys | 80.00K |